SCHEMBL27744409

SCHEMBL27744409

CC(C)(C)C(=O)O[C@H]1CCCNC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A1 P30531 2/20 0.40
SLC6A11 P48066 1/20 0.40
TSHR P16473 1/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SLC6A13 Q9NSD5 1/20 0.40
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP19A1 P11511 1/20 0.36
ROCK1 Q13464 2/20 0.34
IRAK4 Q9NWZ3 1/20 0.33
CHRNB2 P17787 2/20 0.33
CHRNA4 P43681 2/20 0.33
CPN1 P15169 1/20 0.33
CPB2 Q96IY4 1/20 0.33
MAPK1 P28482 1/20 0.32
OPRK1 P41145 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27504346 1.00 SLC6A1 (0.40) SLC6A1SLC6A11TSHRLMNASMN1; SMN2
SCHEMBL27657052 1.00 SLC6A1 (0.40) SLC6A1SLC6A11TSHRLMNASMN1; SMN2
SCHEMBL27908028 0.95 CYP19A1 (0.38) SLC6A1SLC6A11TSHRLMNASMN1; SMN2
SCHEMBL27653752 0.89 SLC6A1 (0.33) SLC6A1SLC6A11SLC6A13CYP19A1
SCHEMBL20617836 0.89 SLC6A1 (0.33) SLC6A1SLC6A11SLC6A13CYP19A1
SCHEMBL27598186 0.89 SLC6A1 (0.33) SLC6A1SLC6A11SLC6A13CYP19A1
SCHEMBL27761386 0.86 CYP19A1 (0.39) SLC6A1SLC6A11TSHRLMNASMN1; SMN2
SCHEMBL28323285 0.82 SLC6A1 (0.40) SLC6A1SLC6A11TSHRLMNASMN1; SMN2
SCHEMBL48890 0.81 CHRNB2 (0.32) ATMCYP19A1CHRNB2CHRNA4
SCHEMBL21003949 0.79 SLC6A1 (0.44) SLC6A1SLC6A11TSHRLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107501275-B It can be used as the compound of ATR kinase inhibitor Votex Pharmaceutical Co., Ltd. (US) 2019-11-22 CN disclosed
CN-107501274-B It can be used as the compound of ATR kinase inhibitor Votex Pharmaceutical Co., Ltd. (US) 2019-11-22 CN disclosed
CN-106573001-A Aminopyridazinone compounds as protein kinase inhibitors 永恒生物科技公司 2017-04-19 CN disclosed
CN-105940004-A Compounds 葛兰素史密斯克莱知识产权发展有限公司 2016-09-14 CN disclosed
CN-105793238-A Substituted benzamides and methods of use thereof 基因泰克公司 2016-07-20 CN disclosed
CN-105764896-A Inhibitors of Bruton's tyrosine kinase 药品循环有限责任公司 2016-07-13 CN disclosed
CN-105143185-A Novel pyrimidine and pyridine compounds and their use HUTCHISON MEDIPHARMA LTD 2015-12-09 CN disclosed
CN-104974140-A 2,3,4,6-tetrasubstituted benzene-1,5-diamine derivatives, preparation method thereof and medicinal application thereof SHANGHAI HAIYAN PHARMA TECHNOLOGY CO LTD 2015-10-14 CN disclosed
CN-104918939-A Purine inhibitors of human phosphatidylinositol 3-kinase MERCK SHARP & DOHME 2015-09-16 CN disclosed
CN-104903325-A COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMA 2015-09-09 CN disclosed
CN-104487441-A Reversible covalent pyrrolo- or pyrazolopyrimidines useful for treatment of cancer and autoimmune diseases PRINCIPIA BIOPHARMA INC 2015-04-01 CN disclosed
CN-104379568-A Quinazolinedione derivative CHUGAI PHARMACEUTICAL CO LTD 2015-02-25 CN disclosed
CN-104379586-A Protein kinase inhibitors PHARMASCIENCE INC 2015-02-25 CN disclosed
CN-103917545-A BTK inhibitors MERCK SHARP & DOHME 2014-07-09 CN disclosed
CN-102740847-A Heteroaryl compounds and uses thereof AVILA THERAPEUTICS INC 2012-10-17 CN disclosed
CN-102083800-A Heteroaryl compounds and uses thereof AVILA THERAPEUTICS AND USES TH 2011-06-01 CN disclosed
CN-101405265-A Amido compounds and their use as pharmaceuticals INCYTE CORP (US) 2009-04-08 CN disclosed